https://www.openbell.ai/ 2026-10-12T23:48:31.548Z hourly 1.0 https://www.openbell.ai/support 2026-10-12T23:48:31.548Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-12T23:48:31.548Z monthly 0.5 https://www.openbell.ai/terms 2026-10-12T23:48:31.548Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-12T23:48:31.548Z hourly 0.8 https://www.openbell.ai/news/HP:1791839587482 2026-10-12T21:13:07.482Z daily 0.9 https://cdn.brandfetch.io/HP/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Maintains Buy on Helmerich & Payne, Raises Price Target to $50 UBS analyst Josh Silverstein has reaffirmed a Buy rating on Helmerich & Payne (NYSE: HP) and increased the price target from $49 to $50. This adjustment reflects positive sentiment towards the company's performance. https://www.openbell.ai/news/ALHC:1791839469293 2026-10-12T21:11:09.293Z daily 0.9 https://cdn.brandfetch.io/ALHC/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Maintains Neutral on Alignment Healthcare, Lowers Price Target to $9 UBS analyst Jonathan Yong has maintained a Neutral rating on Alignment Healthcare (NASDAQ: ALHC) and reduced the price target from $22 to $9. This adjustment reflects a significant decrease in expected valuation for the company. https://www.openbell.ai/news/ULS:1791839349145 2026-10-12T21:09:09.145Z daily 0.9 https://cdn.brandfetch.io/ULS/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Maintains Buy on UL Solutions, Raises Price Target to $97 UBS analyst Joshua Chan has maintained a 'Buy' rating on UL Solutions (NYSE: ULS) and increased the price target from $96 to $97. https://www.openbell.ai/news/MDIA:1791839149971 2026-10-12T21:05:49.971Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=250&height=187 12 Communication Services Stocks Moving In Monday's After-Market Session In Monday's after-market session, MediaCo Holding (NASDAQ: MDIA) shares rose 8.8% to $1.14, with a market value of $86.5 million. Other gainers included VS Media Holdings (NASDAQ: VSME) up 8.14% to $0.84, and Angi (NASDAQ: ANGI) increasing by 8.04% to $6.85, with a market cap of $267.2 million. Conversely, Darkiris (NASDAQ: DKI) saw a significant decline of 14.7% to $0.12, while Dreamland (NASDAQ: TDIC) fell 10.47% to $1.54, with a market cap of $5.7 million. https://www.openbell.ai/news/BMEA:1791839149697 2026-10-12T21:05:49.697Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&height=187 12 Health Care Stocks Moving In Monday's After-Market Session In Monday's after-market session, Biomea Fusion (NASDAQ:BMEA) saw its stock rise by 11.0% to $1.51, with a market value of $102.9 million. Other notable gainers included iTonic Holdings (up 9.53% to $4.02, market cap of $29.7 million) and ARS Pharmaceuticals (up 6.69% to $4.46, market cap of $420.6 million). Conversely, Mobile-health Network experienced a significant decline of 23.7%, falling to $2.32, while Syndax Pharmaceuticals dropped 17.23% to $13.7, with a market cap of $1.5 billion. https://www.openbell.ai/news/SDST:1791839149480 2026-10-12T21:05:49.480Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&height=187 12 Industrials Stocks Moving In Monday's After-Market Session In Monday's after-market session, Stardust Power (NASDAQ: SDST) shares rose by 12.2% to $0.06. SU Group Holdings (NASDAQ: SUGP) saw an increase of 11.04% to $2.01, with a market cap of $9.9 million. Conversely, Linkers Industries (NASDAQ: LNKS) experienced a significant decline of 19.4% to $1.83, with a market cap of $1.5 million. https://www.openbell.ai/news/DAIC:1791839149237 2026-10-12T21:05:49.237Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_1.jpg?width=250&height=187 12 Information Technology Stocks Moving In Monday's After-Market Session In Monday's after-market session, CID Holdco (NASDAQ: DAIC) shares surged by 48.2% to $2.52, with a market value of $5.5 million. Other notable gainers included DarkHorse Technologies (NASDAQ: DRK), which rose 8.81% to $2.47, and Navitas Semiconductor (NASDAQ: NVTS), which increased by 6.1% to $10.6, bringing its market cap to $2.8 billion. Conversely, SmartKem (NASDAQ: SMTK) experienced the largest decline, falling 18.9% to $0.86, with a market value of $1.1 million. https://www.openbell.ai/news/YRD:1791839126337 2026-10-12T21:05:26.337Z daily 0.9 https://cdn.brandfetch.io/YRD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Yiren Digital Says Ning Tang, Executive Chairman And CEO, Is Subject To Criminal Compulsory Measures; Investigation May Impair Ning Tang's Ability To Perform CEO And Chairman Duties; Board And Management To Oversee Operations And Implement Contingency Plans; Has Not Received Official Notice Regarding Investigation Yiren Digital Ltd. announced that its Executive Chairman and CEO, Ning Tang, is subject to criminal compulsory measures due to an investigation involving affiliates of the Company's controlling shareholder. The company has not received official notice regarding the investigation and cannot comment on its specifics. This situation may impair Tang's ability to perform his duties, prompting the Board and management to oversee operations and implement contingency plans. The investigation could negatively impact the company's reputation and financial condition. https://www.openbell.ai/news/MIRM:1791838979345 2026-10-12T21:02:59.345Z daily 0.9 https://cdn.brandfetch.io/MIRM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $184 Citigroup analyst Yigal Nochomovitz has maintained a Buy rating on Mirum Pharmaceuticals (NASDAQ: MIRM) and increased the price target from $160 to $184. This adjustment reflects positive expectations for the company's performance in the market. https://www.openbell.ai/news/PR:1791838921515 2026-10-12T21:02:01.515Z daily 0.9 https://cdn.brandfetch.io/PR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on Permian Resources, Raises Price Target to $28 Citigroup analyst Paul Diamond has reiterated a Buy rating on Permian Resources (NYSE: PR) and increased the price target from $24 to $28. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/ARMK:1791838875088 2026-10-12T21:01:15.088Z daily 0.9 https://cdn.brandfetch.io/ARMK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on Aramark, Raises Price Target to $75.5 Citigroup analyst Leo Carrington has reiterated a Buy rating on Aramark (NYSE: ARMK) and increased the price target from $74 to $75.5. This adjustment reflects a positive outlook for the company in the market. https://www.openbell.ai/news/PENN:1791838703998 2026-10-12T20:58:23.998Z daily 0.9 https://cdn.brandfetch.io/PENN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Neutral on PENN Entertainment, Lowers Price Target to $17 Citigroup analyst James Hardiman has maintained a Neutral rating on PENN Entertainment (NASDAQ: PENN) and has lowered the price target from $22 to $17. https://www.openbell.ai/news/WHR:1791838400050 2026-10-12T20:53:20.050Z daily 0.9 https://cdn.brandfetch.io/WHR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Neutral on Whirlpool, Lowers Price Target to $32 Citigroup analyst Kyle Menges has maintained a Neutral rating on Whirlpool (NYSE: WHR) and has reduced the price target from $48 to $32. This adjustment reflects a more cautious outlook on the company's performance. https://www.openbell.ai/news/SKK:1791838199152 2026-10-12T20:49:59.152Z daily 0.9 https://cdn.brandfetch.io/SKK/w/400/h/400?c=1idopYfmtR7ZKg8QMud SKK Holdings Announces The Closing Of Its Asset Purchase Agreement With Rantizo; Transaction Is Valued At ~ $258.8M; Co. To Change Its Name To "Rantizo," And Its Class A Ordinary Shares Are Expected To Begin Trading On The Nasdaq Under The New Ticker Symbol "RNTZ" On October 13, 2026 SKK Holdings Limited has completed its asset purchase agreement with Rantizo, Inc., valued at approximately $258.8 million, acquiring Rantizo's drone assets for agricultural and commercial applications. Following the transaction, SKK Holdings will change its name to 'Rantizo,' with its Class A ordinary shares expected to trade on Nasdaq under the new ticker symbol 'RNTZ' starting October 13, 2026. Additionally, Rantizo will acquire 1,085,264 Class B ordinary shares for $8 million, and the company has granted Management Shares valued at $12 million. https://www.openbell.ai/news/PCAR:1791838078069 2026-10-12T20:47:58.069Z daily 0.9 https://cdn.brandfetch.io/PCAR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Neutral on PACCAR, Lowers Price Target to $115 Citigroup analyst Kyle Menges has maintained a Neutral rating on PACCAR (NASDAQ: PCAR) while lowering the price target from $140 to $115. This adjustment reflects a change in the firm's outlook on the company's stock performance. https://www.openbell.ai/news/NVTS:1791837796636 2026-10-12T20:43:16.636Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Navitas-Semiconductor-Corp-NASDAQNVTS.jpg?width=250&height=187 Navitas Semiconductor Stock Rises After Hours: Here's Why Navitas Semiconductor Corp (NASDAQ: NVTS) shares rose 6.21% in after-hours trading to $10.61 following the announcement of a new 24 kW, 800 V-to-12 V DC-DC power delivery board developed in collaboration with Nvidia. The board, utilizing GaNFast technology, is designed to support the Nvidia MGX ecosystem and enhance power delivery for AI data centers, achieving a target efficiency of 97% at full load. This innovation aims to address the power demands of advanced AI infrastructure. https://www.openbell.ai/news/KR:1791837553786 2026-10-12T20:39:13.786Z daily 0.9 https://cdn.brandfetch.io/KR/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Kroger Plans To Slash 37% Of Corporate Jobs In Next Three Year; Will Eliminate About 3,000 Roles Across Various Functions' - Bloomberg News Kroger plans to reduce its corporate workforce by 37% over the next three years, resulting in the elimination of approximately 3,000 roles across various functions. This strategic move is part of the company's efforts to streamline operations and improve efficiency. The announcement may impact Kroger's stock performance and overall market position in the retail sector. https://www.openbell.ai/news/RDDT:1791837497057 2026-10-12T20:38:17.057Z daily 0.9 https://cdn.brandfetch.io/RDDT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching Reddit; Shares Trading Lower, Traders Circulate Unconfirmed Rumor Suggesting Ukrainian Strikes On Russian Technology Giant Yandex's Data Centers Have Been Followed By A Dramatic Decline In Automated Online Activity, Particularly On Reddit openbell Financial News https://www.openbell.ai/news/RDDT:1791837383430 2026-10-12T20:36:23.430Z daily 0.9 https://cdn.brandfetch.io/RDDT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching Reddit; Shares Trading Lower, Traders Circulate Unconfirmed Rumor Suggesting Ukrainian Strikes On Russian Technology Giant Yandex's Data Centers Have Been Followed By A Dramatic Decline In Automated Online Activity, Particularly On Reddit openbell Financial News https://www.openbell.ai/news/MCD:1791837341525 2026-10-12T20:35:41.525Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/3-Limited-Time-McMuffins-Heat-Up-McDonal.jpg?width=250&height=187 McDonald’s Stock ‘Moderately Undervalued’: Former Hedge Fund Manager Says Good Buying Opportunity McDonald's Corp (NYSE: MCD) stock has reached four-year lows, prompting former hedge fund manager Whitney Tilson to label it as 'moderately undervalued' and a potential buying opportunity. He noted that the stock has declined 14% since June, while highlighting the company's strong margins, doubled free cash flow since 2018, and a 3%+ dividend yield. Tilson pointed out that McDonald's trades at 17.6 times next year's consensus earnings estimates, slightly below its historical average of 19.7 times, suggesting a favorable valuation despite recent growth challenges. https://www.openbell.ai/news/RAL:1791837266705 2026-10-12T20:34:26.705Z daily 0.9 https://cdn.brandfetch.io/RAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on Ralliant, Raises Price Target to $85 Citigroup analyst Andrew Kaplowitz has maintained a Buy rating on Ralliant (NYSE: RAL) and increased the price target from $82 to $85. This adjustment reflects a positive outlook for the company's performance. https://www.openbell.ai/news/MUR:1791837141384 2026-10-12T20:32:21.384Z daily 0.9 https://cdn.brandfetch.io/MUR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Murphy Oil Announces Offshore Appraisal Success In Côte d’Ivoire, Vietnam Exploration Discovery And First Oil At Lac Da Vang Field Murphy Oil Corporation (NYSE: MUR) reported successful appraisal at the Bubale West-1X well offshore Côte d’Ivoire and an exploration discovery at the Lac Da Trang North-1X well offshore Vietnam. The company also announced the first oil production from the Lac Da Vang field in Vietnam and ongoing production from the Chinook #8 development well in the Gulf of America. https://www.openbell.ai/news/AMAT:1791837073098 2026-10-12T20:31:13.098Z daily 0.9 https://cdn.brandfetch.io/AMAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Applied Materials Demonstrates Its $5B Equipment And Process Innovation And Commercialization Center Applied Materials, Inc. has launched its $5 billion Equipment and Process Innovation and Commercialization (EPIC) Center, which is the largest facility focused on semiconductor process technology and manufacturing equipment R&D. The center aims to foster collaboration among chipmakers, systems companies, equipment partners, and university researchers to enhance chip innovation for the AI era. https://www.openbell.ai/news/BTDR:1791837058992 2026-10-12T20:30:58.992Z daily 0.9 https://cdn.brandfetch.io/BTDR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bitdeer Announces 8-Year Agreement For 60MW Malaysia AI Data Center Expected Online In Q1 2028 openbell Financial News https://www.openbell.ai/news/PEP:1791837001855 2026-10-12T20:30:01.855Z daily 0.9 https://cdn.brandfetch.io/PEP/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'PepsiCo Cuts Estimates for Poppi Payout While Soda Sales Slump' - Bloomberg News PepsiCo has reduced its payout estimates for the Poppi brand amid declining soda sales. The company is facing challenges in the beverage market, which has prompted this adjustment. Specific financial figures regarding the revised payout were not disclosed, but the move reflects broader industry trends affecting soda consumption. https://www.openbell.ai/news/NVT:1791836971507 2026-10-12T20:29:31.507Z daily 0.9 https://cdn.brandfetch.io/NVT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on nVent Electric, Raises Price Target to $228 Citigroup analyst Vladimir Bystricky has reaffirmed a Buy rating on nVent Electric (NYSE: NVT) and increased the price target from $215 to $228. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/SDRL:1791836953485 2026-10-12T20:29:13.485Z daily 0.9 https://cdn.brandfetch.io/SDRL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Seadrill Secures ~$420M Indonesia Drilling Contract And Multiple Rig Extensions In Malaysia And Angola; Contract Has An Estimated Firm Duration Of 880 Days, With Priced Options For Up To An Additional 880 Days; Expected To Commence In H1 2027 Seadrill Limited has secured a contract valued at approximately $420 million for the West Carina rig in Indonesia, with a firm duration of 880 days and options for an additional 880 days, expected to start in H1 2027. The company also extended operations for the West Capella in Malaysia by 240 days, adding a total of approximately $94 million in contract value, and extended the Sonangol Libongos rig in Angola for about three years, committing it through January 2030. Additionally, the Sevan Louisiana rig has been awarded a 25-day contract in the U.S. Gulf, commencing in November 2026. https://www.openbell.ai/news/APG:1791836439201 2026-10-12T20:20:39.201Z daily 0.9 https://cdn.brandfetch.io/APG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on APi Group, Raises Price Target to $55 Citigroup analyst Andrew Kaplowitz has maintained a 'Buy' rating on APi Group (NYSE: APG) and increased the price target from $54 to $55. https://www.openbell.ai/news/NVTS:1791836437530 2026-10-12T20:20:37.530Z daily 0.9 https://cdn.brandfetch.io/NVTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Navitas Semiconductor Unveils 24 kW GaN-Powered 800V-To-12V Power Delivery Board For NVIDIA AI Data Centers Navitas Semiconductor (NASDAQ: NVTS) has introduced a 24 kW, 800 V-to-12 V DC-DC power delivery board (PDB) powered by GaNFast™ technology, developed in collaboration with NVIDIA to enhance AI data centers. This new PDB expands Navitas' offerings in the 800 VDC AI data-center sector, following their earlier release of a 20 kW, 800 V-to-6 V PDB with NVIDIA. The product will be showcased at the OCP Global Summit 2026, aligning with Navitas' strategic goal to replace legacy silicon with advanced GaN and SiC technologies. https://www.openbell.ai/news/NVTS:1791836320593 2026-10-12T20:18:40.593Z daily 0.9 https://cdn.brandfetch.io/NVTS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Navitas Semiconductor shares are trading higher after the company announced its latest 24 kW, 800 V-to-12 V DC-DC power delivery board, powered by GaNFast technology and developed in collaboration with NVIDIA, to support the NVIDIA MGX ecosystem and advance 800 VDC power architectures for AI data centers. openbell Financial News https://www.openbell.ai/news/SDRL:1791836183834 2026-10-12T20:16:23.834Z daily 0.9 https://cdn.brandfetch.io/SDRL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Seadrill Announces ~$420M Contract For West Carina With Unnamed Operator In Indonesia, Plus Extensions For West Capella And Sonangol Libongos openbell Financial News https://www.openbell.ai/news/JNJ:1791835926447 2026-10-12T20:12:06.447Z daily 0.9 https://cdn.brandfetch.io/JNJ/w/400/h/400?c=1idopYfmtR7ZKg8QMud Johnson & Johnson Announces Three-Year Data From Its Phase 3 GALAXI 2, 3 Trials Of TREMFYA Demonstrate Efficacy, Consistent Profile To Treat Crohn's Disease Johnson & Johnson (NYSE: JNJ) announced three-year data from its Phase 3 GALAXI 2 and 3 trials, demonstrating the efficacy and consistent safety profile of TREMFYA (guselkumab) for treating moderately to severely active Crohn's disease. The Week 144 long-term extension results will be presented at the American College of Gastroenterology (ACG) 2026 Annual Scientific Meeting, highlighting clinical and endoscopic outcomes across TREMFYA maintenance regimens. https://www.openbell.ai/news/NRIX:1791835851391 2026-10-12T20:10:51.391Z daily 0.9 https://cdn.brandfetch.io/NRIX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nurix Therapeutics shares are trading higher after the company reported better-than-expected Q3 financial results. openbell Financial News https://www.openbell.ai/news/NRIX:1791835794634 2026-10-12T20:09:54.634Z daily 0.9 https://cdn.brandfetch.io/NRIX/w/400/h/400?c=1idopYfmtR7ZKg8QMud CORRECTION: Nurix Therapeutics Q3 EPS $4.73 Beats $3.98 Estimate, Sales $673.064M Beat $411.481M Estimate Nurix Therapeutics (NASDAQ: NRIX) reported Q3 earnings of $4.73 per share, exceeding the analyst estimate of $3.98 by 18.84%, and representing a 559.22% increase from a loss of $(1.03) per share in the same period last year. The company also reported quarterly sales of $673.064 million, surpassing the consensus estimate of $411.481 million by 63.57%, and showing an 8.43K% increase from $7.894 million in the prior year. https://www.openbell.ai/news/FORM:1791835785285 2026-10-12T20:09:45.285Z daily 0.9 https://cdn.brandfetch.io/FORM/w/400/h/400?c=1idopYfmtR7ZKg8QMud FormFactor shares are trading higher after the company announced it has entered into a broad technology collaboration with Teradyne, aimed at accelerating the development, validation, and high-volume production deployment of next-generation semiconductor devices. openbell Financial News https://www.openbell.ai/news/ONCY:1791835689033 2026-10-12T20:08:09.033Z daily 0.9 https://cdn.brandfetch.io/ONCY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Oncolytics Biotech Expands Pelareorep Patent Protection Strategy Through 2044 Oncolytics Biotech Inc. has expanded its patent protection strategy for pelareorep, an immunotherapy for cancer, with a new method of use patent issued in several countries and a U.S. patent expected soon. The company has three pending patent applications, including one that will be converted to a Track One application this quarter for prioritized examination. Additionally, Oncolytics is collaborating with an academic partner to develop a 'next generation' pelareorep, which is anticipated to support a new composition of matter patent, potentially extending protection for up to 20 years from the filing date. https://www.openbell.ai/news/ICCC:1791835610565 2026-10-12T20:06:50.565Z daily 0.9 https://cdn.brandfetch.io/ICCC/w/400/h/400?c=1idopYfmtR7ZKg8QMud ImmuCell Reports Q3 Preliminary Sales Of $8M, Up 46% YoY ImmuCell Corporation (NASDAQ: ICCC) reported preliminary, unaudited sales of $8 million for Q3 2026, marking a 46% increase year-over-year. Domestic sales contributed $6.9 million, reflecting a 29.2% increase compared to the same period in 2025. For the nine months ending September 30, 2026, total sales reached $25.6 million, a 27.8% increase from the previous year. https://www.openbell.ai/news/SNDX:1791835509997 2026-10-12T20:05:09.997Z daily 0.9 https://cdn.brandfetch.io/SNDX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Syndax Pharmaceuticals shares are trading lower after the company announced that the MAXPIRe Phase 2 trial of axatilimab in idiopathic pulmonary fibrosis did not meet its primary endpoint of the annualized rate of decline in forced vital capacity. openbell Financial News https://www.openbell.ai/news/FORM:1791835416566 2026-10-12T20:03:36.566Z daily 0.9 https://cdn.brandfetch.io/FORM/w/400/h/400?c=1idopYfmtR7ZKg8QMud FormFactor And Teradyne Enter Into A Broad Technology Collaboration Aimed At Accelerating The Development, Validation, And High-Volume Production Deployment Of Next-generation Semiconductor Devices FormFactor, Inc. and Teradyne, Inc. have announced a technology collaboration to enhance the development and production of next-generation semiconductor devices. This partnership will leverage FormFactor's expertise in probe technologies and Teradyne's automated test platforms to address increasing semiconductor complexity. Additionally, Teradyne will purchase shares of FormFactor common stock as part of the agreement. https://www.openbell.ai/news/LSCC:1791835359507 2026-10-12T20:02:39.507Z daily 0.9 https://cdn.brandfetch.io/LSCC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Lattice Semiconductor Announces Its Lattice Sentry Now Delivers CNSA 2.0-Aligned, NIST-Compliance Protection Throughout AI Data Centers Lattice Semiconductor (NASDAQ: LSCC) has announced the release of version 5.0 of its Lattice Sentry solution stack, which is the first post-quantum cryptography-enabled Platform Firmware Resilience and attestation solution. This update provides CNSA 2.0-aligned, NIST-compliant protection across AI data centers and critical infrastructure, enhancing security against quantum threats. The new solution offers system designers a validated and production-ready path to quantum-resistant security. https://www.openbell.ai/news/CYTK:1791835356592 2026-10-12T20:02:36.592Z daily 0.9 https://cdn.brandfetch.io/CYTK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cytokinetics Presents Additional Data From Assessment Comparing Aficamten To Placebo On Cardiac Endpoints In Adults With Non-Obstructive HCM At HFSA Annual Scientific Meeting 2026 Cytokinetics, Incorporated (NASDAQ: CYTK) presented additional data from the ACACIA-HCM study at the HFSA Annual Scientific Meeting 2026, focusing on the exercise performance, treatment effect, dose titration, and safety of Aficamten in adults with non-obstructive hypertrophic cardiomyopathy (HCM). The findings further characterize the impact of Aficamten compared to placebo on cardiac endpoints. https://www.openbell.ai/news/AVBP:1791835330935 2026-10-12T20:02:10.935Z daily 0.9 https://cdn.brandfetch.io/AVBP/w/400/h/400?c=1idopYfmtR7ZKg8QMud ArriVent BioPharma Doses First Patient In Phase 1 Trial Of Dual-Target ADC ARR-002 For Ovarian And Endometrial Cancer ArriVent BioPharma, Inc. (NASDAQ: AVBP) has initiated a Phase 1 trial for its dual-target antibody-drug conjugate ARR-002, aimed at treating ovarian and endometrial cancer, marking the second ADC from its portfolio to enter clinical testing. The drug targets MUC16 and NaPi2b, which are over-expressed in these cancers, potentially enhancing treatment efficacy. Additionally, in August 2026, ArriVent signed an exclusive licensing agreement with Shanghai Allist Pharmaceuticals to develop ARR-002 in Greater China, retaining all other rights. https://www.openbell.ai/news/SNDX:1791835318778 2026-10-12T20:01:58.778Z daily 0.9 https://cdn.brandfetch.io/SNDX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Syndax Says Phase 2 Trial Of Axatilimab In Idiopathic Pulmonary Fibrosis Missed Primary Endpoint, Halts IPF Development openbell Financial News https://www.openbell.ai/news/ASST:1791835286729 2026-10-12T20:01:26.729Z daily 0.9 https://cdn.brandfetch.io/ASST/w/400/h/400?c=1idopYfmtR7ZKg8QMud Maxim Group Maintains Buy on Strive, Raises Price Target to $37 Maxim Group analyst Matthew Galinko has maintained a Buy rating on Strive (NASDAQ: ASST) and raised the price target from $21 to $37. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/SPY:1791835253935 2026-10-12T20:00:53.935Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Artificial-Intelligence-stocks-Shutterst.jpg?width=250&height=187 S&P 500 Dominated by AI Stocks, Adding SpaceX Would Create History Last Seen in 1880s AI stocks now constitute 49% of the S&P 500, with 41 AI pure plays accounting for approximately two-thirds of the index's year-to-date market cap changes. If SpaceX were included in the index, AI-related stocks would rise to 51%, and with potential future IPOs like Anthropic and OpenAI, this could increase to around 55% by 2027. This level of concentration in AI stocks has not been seen since the 1880s when railroads dominated the market. https://www.openbell.ai/news/ABTC:1791835125232 2026-10-12T19:58:45.232Z daily 0.9 https://cdn.brandfetch.io/ABTC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Maxim Group Maintains Buy on American Bitcoin, Raises Price Target to $16 Maxim Group analyst Matthew Garland has reaffirmed a Buy rating on American Bitcoin (NASDAQ: ABTC) and increased the price target from $15 to $16. This adjustment reflects the firm's confidence in the company's future performance. https://www.openbell.ai/news/VFC:1791834769066 2026-10-12T19:52:49.066Z daily 0.9 https://cdn.brandfetch.io/VFC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on VF, Raises Price Target to $24 Barclays analyst Adrienne Yih has maintained an Overweight rating on VF Corporation (NYSE: VFC) and raised the price target from $23 to $24. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/MU:1791834644075 2026-10-12T19:50:44.075Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Image-Of-A-Micron-High-Bandwidth-Memory-.jpg?width=250&height=187 China Chip Concerns Hit Micron, SanDisk: Monday's Selloff Brings Double Pain for This ETF The Roundhill Memory ETF (BATS: DRAM) and its leveraged counterpart, the Roundhill T-REX 2X Long DRAM Daily Target ETF (BATS: RAM), experienced significant declines of 4.4% and 8.8%, respectively, due to concerns over increased competition from China's ChangXin Memory Technologies (CXMT). Collectively, major companies Micron Technology, SK Hynix, and SanDisk lost approximately $108 billion in market value. The ETFs are heavily exposed to memory manufacturers, with Samsung Electronics, SK Hynix, Micron, and SanDisk being key holdings, and the impact of CXMT's advancements on pricing remains uncertain. https://www.openbell.ai/news/PSX:1791834069253 2026-10-12T19:41:09.253Z daily 0.9 https://cdn.brandfetch.io/PSX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Equal-Weight on Phillips 66, Raises Price Target to $282 Barclays analyst Theresa Chen has maintained an Equal-Weight rating on Phillips 66 (NYSE: PSX) while raising the price target from $216 to $282. This adjustment reflects an optimistic outlook for the company's stock performance. https://www.openbell.ai/news/MPC:1791833966284 2026-10-12T19:39:26.284Z daily 0.9 https://cdn.brandfetch.io/MPC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Maintains Overweight on Marathon Petroleum, Raises Price Target to $488 Barclays analyst Theresa Chen has maintained an Overweight rating on Marathon Petroleum (NYSE: MPC) and increased the price target from $321 to $488. This adjustment reflects a positive outlook on the company's performance.